{
  "docId": "019dd923-622c-750b-8b99-62a16d2a2f71",
  "docSlug": "747988e81365",
  "documentTitle": "Hims & Hers Health, Inc. (HIMS)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-07-13 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 61,
  "pageCount": 105,
  "prevPage": 60,
  "nextPage": 62,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Includes a screenshot of a negative Glassdoor review to support the claim of operational issues.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "callout_box",
    "screenshot",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-62a16d2a2f71/61",
  "deckHref": "/decks/019dd923-622c-750b-8b99-62a16d2a2f71",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-62a16d2a2f71.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-62a16d2a2f71#slide-61",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.97,
        "x": 0.015,
        "y": 0.28
      },
      "kind": "callout",
      "text": "Apostrophe Further Increased HIMS' Reliance On The Troubled ITC Compounding And Truepill",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2199fd89-ad56-44a3-9395-88bd93089990",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.47,
        "x": 0.515,
        "y": 0.76
      },
      "kind": "callout",
      "text": "We believe investors should be concerned when former employees note that “safety is in jeopardy”, suggesting insourcing may not improve HIMS' risk profile.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8dbe28aa-188a-4608-8616-dee5896583fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.68,
        "x": 0.16,
        "y": 0.87
      },
      "kind": "callout",
      "text": "In addition, we find that neither Apostrophe nor XeCare are listed as a registered human drug compounding outsourcing facility on the FDA website.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e05022ee-d38a-422a-8fa5-1a1f86493622",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "We believe investors should be concerned when former employees note that “safety is in jeopardy”, suggesting insourcing may not improve HIMS’ risk profile.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0f1d-76e6-8707-330daeb2fa90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.38,
        "w": 0.47,
        "x": 0.515,
        "y": 0.36
      },
      "kind": "image",
      "text": "Glassdoor review screenshot for XeCare facility",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23402ad2-8fd6-447c-97b7-6050412230ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.48,
        "x": 0.015,
        "y": 0.36
      },
      "kind": "image",
      "text": "Apostrophe website screenshot showing ITC Compounding and Truepill logos",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd04f799-ce16-422e-a38a-2f399cdfc63e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.97,
        "x": 0.015,
        "y": 0.175
      },
      "kind": "paragraph",
      "text": "Despite its small size, Apostrophe relies on both ITC Compounding and Truepill, further increasing HIMS operating risks and highlighting its own modest internal capabilities. While the ramp of XeCare in Ohio represents a materially larger warehouse capability, we find indications the pharmacy side of the operation is suffering potentially serious growing pains.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ba8c67f-c55c-45d7-9a9d-9c53ddc41389",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Management is terrible, they are very unclear with what they want done, always had to play a guessing game with what tasks could be done. people have no clear understanding of who can work in the pharmacy as upper management overstep and delegates tasks to people who are not qualified to do tasks. If something happens and safety is in jeopardy, it is kept a secret from all employees even though they promote an environment where transparency and clear communication happens. — Certified Pharmacy Technician in New Albany, OH (Glassdoor)",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0f1d-76e6-8707-34033f09f013",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.4,
        "x": 0.015,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Source: Apostrophe website, Glassdoor, Spruce Point red underline emphasis",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b6046ede-3664-47d8-b57b-ddb88731df65",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.68,
        "x": 0.305,
        "y": 0.015
      },
      "kind": "title",
      "text": "Apostrophe Increases HIMS' Reliance On ITC Compounding And Truepill, While The Ramp At XeCare Seems To Be Struggling",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f644ce68-5dc8-40a5-a8e0-302a75b829b0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "553a75a8-6b94-4531-9b77-4a5f2af96e4f",
      "evidence": "Exposing operational risks and potential regulatory non-compliance to challenge company narrative.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [
    {
      "to": 105,
      "from": 15,
      "beatId": "e37982bf-a669-4ff0-9d59-9ad104610c60",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The document presents numerous contradictions and issues with HIMS' business model, operations, and financials",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}